New research shows prenatal PFAS exposure reduces maternal HOMA-β by 34%, with epigenetic and oxidative stress markers providing mechanistic insights. Global regulatory responses are evolving. A grou...
Emerging research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and long-term metabolic disorders through beta cell disruption. Groundbreaking 2024 studies demonst...
Prenatal PFAS exposure linked to lifelong maternal diabetes risk and epigenetic changes in offspring
New research reveals prenatal PFAS exposure significantly increases maternal diabetes risk and may cause epigenetic changes affecting offspring metabolic health. Groundbreaking studies show PFAS chemi...
Recent research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and postpartum metabolic disorders, with socioeconomic disparities in exposure levels. Emerging evide...
Emerging research shows prenatal PFAS exposure significantly impacts maternal metabolic health, increasing risks of gestational diabetes and long-term beta cell dysfunction. Groundbreaking studies dem...
Recent studies confirm PFAS chemicals disrupt insulin signaling and beta-cell function, with new EPA regulations setting strict water limits while exposure routes expand through food and consumer prod...
Recent research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and insulin resistance, with new data revealing widespread contamination in pregnant women. Emerging ...
New research shows prenatal PFAS exposure disrupts maternal beta-cell function for 7-9 years postpartum, with significant implications for metabolic health and policy. Groundbreaking study reveals per...
Recent research shows prenatal PFAS exposure significantly impacts maternal metabolic health, increasing diabetes risk and impairing beta-cell function decades after pregnancy. Emerging evidence demon...
Emerging research shows prenatal PFAS exposure significantly increases risks of persistent maternal metabolic disorders, including beta cell dysfunction and insulin resistance. Groundbreaking cohort s...